Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

SRPT holding history

Sarepta Therapeutics, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SRPT overviewAll 13F holders of SRPTFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of SRPT by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−11,000−100.0%Sold outHolders
Q3 202511,000$212.0K<0.1%00.0%UnchangedHolders
Q2 202511,000$188.0K<0.1%−19,690−64.2%ReducedHolders
Q1 202530,690$1.96M<0.1%−24,843−44.7%ReducedHolders
Q4 202455,533$6.75M<0.1%+16,623+42.7%AddedHolders
Q3 202438,910$4.86M<0.1%+2,319+6.3%AddedHolders
Q2 202436,591$5.78M<0.1%+12,393+51.2%AddedHolders
Q1 202424,198$3.13M<0.1%−1,718−6.6%ReducedHolders
Q4 202325,916$2.50M<0.1%+2,156+9.1%AddedHolders
Q3 202323,760$2.88M<0.1%+1,972+9.1%AddedHolders
Q2 202321,788$2.50M<0.1%−4,336−16.6%ReducedHolders
Q1 202326,124$3.60M<0.1%+522+2.0%AddedHolders
Q4 202225,602$3.32M<0.1%−6,886−21.2%ReducedHolders
Q3 202232,488$3.70M<0.1%−5,172−13.7%ReducedHolders
Q2 202237,660$2.82M<0.1%+236+0.6%AddedHolders
Q1 202237,424$2.92M<0.1%+22,046+143.4%AddedHolders
Q4 202115,378$1.39M<0.1%+530+3.6%AddedHolders
Q3 202114,848$1.37M<0.1%−163,720−91.7%ReducedHolders
Q2 2021178,568$13.9M<0.1%+164,586+1,177.1%AddedHolders
Q1 202113,982$1.04M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.